Following the success of Pablo Duque´s presentation, held on 24 January and dedicated of transdisciplinarity, NeuronUP Academy plans to continue throughout 2018 with different free cognitive and rehabilitation training sessions
The neuropsychologist Lucía Zumárraga will be the second speaker of NeuronUP Academy. On Tuesday 20 February Zumárraga will give an online and free presentation on the role of the neuropsychologist in early life care (0-6 years).
Lucía Zumárraga Profile
Degree in Clinical Psychology from Comillas Pontifical University (2002). Master in Neurorehabilitation (Institut Guttmann, UAB). Master in Child and Adolescent Clinical Psychology (ILD, Madrid), Doctorate in Neurosciences (DEA, in Complutense University of Madrid).
Lucía Zumárraga‘s professional career of more than 10 years focuses on the field of pediatric clinical psychology and more specifically in the field of disability. Up until 2012, Zumárraga worked in the Neuropsychological and Research Department of the Guttmann Institute of Neurorehabilitation in Barcelona. She is currently the Director at NeuroPed, a Pediatric Neurodevelopment Center.
What is NeuronUP Academy?
This initiative was born with the idea that neurorehabilitation professionals expand their knowledge by attending free training provided by national and international authorities in the field of rehabilitation and cognitive stimulation.
This online academy is open to all professionals and students involved in processes of rehabilitation and cognitive stimulation and there will be exclusive training for NeuronUP users.
Confirmed speakers include:
- Pablo Duque (finished presentation)
- Lucía Zumárraga
- Juan Carlos Arango
- Marcos Ríos
- Elena Muñoz
- Ignacio Sánchez Cubillo
- Ángel Sánchez Cabeza
- José López
- Rafael Rodríguez
If you want to know more about NeuronUP Academy speakers, visit the following link: https://blog.neuronup.com/en/neuronup-academy-neurorehabilitation/
- Asperger Syndrome from the perspective of neuropsychology - February 18, 2021
- 5 movies depicting neurodegenerative diseases - February 11, 2021
- Cognitive impairment in people with epilepsy - February 8, 2021